Madsen P O, Baumueller A, Frimodt-Møller N, Hoyme U, Lau C, Maigaard S, Nielsen O S, Welling P G
Scand J Infect Dis Suppl. 1980;Suppl 23:128-31.
Netilmicin was investigated in the treatment of complicated urinary tract infection in 169 elderly male patients. It was found to be safe and effective at the dose levels of 1.0-2.5 mg/kg, three times a day, or 2 mg/kg twice a day, eliminating approximately 50-60% of the infections. The serum half-life of netilmicin was 2-3 hours in subjects with normal renal function but increased to 10-14 hours in subjects with severe uremia. When the dosage was adjusted according to the patient's weight and serum creatinine, some nephrotoxicity occurred, possibly due to drug accumulation. Therefore, we suggest that the dose be adjusted according to reduction in creatinine clearance and when possible, monitoring serum concentrations during treatment.
对169例老年男性复杂尿路感染患者进行了奈替米星治疗研究。结果发现,在剂量为1.0 - 2.5毫克/千克、每日3次或2毫克/千克、每日2次时,该药安全有效,可消除约50 - 60%的感染。在肾功能正常的受试者中,奈替米星的血清半衰期为2 - 3小时,但在严重尿毒症患者中延长至10 - 14小时。当根据患者体重和血清肌酐调整剂量时,出现了一些肾毒性,可能是由于药物蓄积所致。因此,我们建议根据肌酐清除率降低情况调整剂量,并在可能的情况下,在治疗期间监测血清浓度。